Home / Inspections / 853863

FDA Inspection 853863 — AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP — FEI 1825662

The FDA completed an inspection of AstraZeneca Pharmaceuticals LP on October 25, 2013 in Mount Vernon, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 25, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mount Vernon, IN (United States)

Facility

Other inspections at this facility

  • 1218331 (VAI Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 965123 (NAI Thu Jan 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 798609 (NAI Thu Sep 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 751470 (VAI Fri Oct 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 741276 (NAI Fri Aug 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources